Baker Bros. Advisors LP Harmony Biosciences Holdings, Inc. Transaction History

Baker Bros. Advisors LP

  • $9.34 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$27.56 - $40.37 $1.55 Million - $2.28 Million
-56,400 Reduced 31.33%
123,600 $4.08 Million
Q4 2020

Feb 16, 2021
SELL
$31.74 - $51.34 $6.98 Million - $11.3 Million
-220,000 Reduced 55.0%
180,000 $6.51 Million
Q3 2020

Nov 16, 2020
BUY
$30.96 - $44.39 $12.4 Million - $17.8 Million
400,000 New
400,000 $13.6 Million

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.2M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email